-
Joining us as a presenter at the Evolution Summit this March is Dmitri Lissin, Chief Medical Officer at
#Scilex Pharmaceuticals.#mePharma#Evolution#Clinical Trials Find out more: https://bit.ly/3aPVvla pic.twitter.com/b118xZnnCO
-
#Scilex Raises $140 Million to Support Commercialization of#Non-Opioid#Topical#Pain#Medication System http://www.cafepharma.com/cpwire/article/scilex-raises-140-million-support-commercialization-non-opioid-topical-pain …@cafepharma -
#Scilex Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Up... Read more: http://owler.us/adieF0 -
#Scilex FDA to review re-submitted application for Sorrento's lidocaine patch. Read more: http://owler.us/adhtar -
#Scilex FDA Acknowledges Receipt Of Sorrento, NDA For ZTlido; PDUFA Date Set For February 28, 2... Read more: http://owler.us/adhl0O -
#Scilex Sorrento subsidiary Scintilla acquires pain specialist Semnur for $200m ... Read more: http://owler.us/abnbSh -
#Scilex Sorrento subsidiary Scintilla to go it alone with $200M pain biotech buy. Read more: http://owler.us/abaVH3 -
SCILEX Study Suggests Underutilization of Recommended First-Line Lidocaine Patches. Read full release: http://ow.ly/ejkf300abxy
#SCILEX -
SCILEX Pharmaceuticals Announces Addition of Bob Rappaport, M.D., to Scientific Advisory Board http://ow.ly/4neNYa
#SCILEX -
Business People on the Move http://ow.ly/10Afuv
#SCILEX -
SCILEX Pharmaceuticals Announces Executive Hires http://ow.ly/YX26I
#Scilex -
-
#SCILEX Pharmaceuticals Completes#Trial Enrollment for Ztlido(TM) http://prn.to/1oCDUkx
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.